MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

Search

Atossa Genetics Inc

Atvērts

0.89 -1.11

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

0.85

Max

0.91

Galvenie mērījumi

By Trading Economics

Ienākumi

-371K

-6.7M

Darbinieki

15

EBITDA

-766K

-7.1M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+518.68% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 11. aug.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

13M

121M

Iepriekšējā atvēršanas cena

2

Iepriekšējā slēgšanas cena

0.89

Tehniskais rādītājs

By Trading Central

Pārliecība

Bullish Evidence

Atossa Genetics Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 15. jūl. 23:41 UTC

Tirgus saruna

Nikkei May Trade in Range Amid Tariff Uncertainty -- Market Talk

2025. g. 15. jūl. 23:40 UTC

Tirgus saruna

Gold Edges Higher on Possible Position Adjustments -- Market Talk

2025. g. 15. jūl. 23:05 UTC

Tirgus saruna

Auckland International Airport Passenger Growth May Disappoint Again -- Market Talk

2025. g. 15. jūl. 21:36 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 15. jūl. 21:36 UTC

Tirgus saruna

Canada CPI Data Fuel Rate-Prediction Revisions -- Market Talk

2025. g. 15. jūl. 20:50 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2025. g. 15. jūl. 20:50 UTC

Tirgus saruna
Peļņas

Financial Services Roundup: Market Talk

2025. g. 15. jūl. 20:50 UTC

Tirgus saruna

Auto & Transport Roundup: Market Talk

2025. g. 15. jūl. 20:50 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2025. g. 15. jūl. 20:14 UTC

Iegādes, apvienošanās, pārņemšana

Chinese EV Makers to Combine. Geely Is Buying Zeekr. -- Barrons.com

2025. g. 15. jūl. 20:07 UTC

Peļņas

BlackRock Shares Tumble After Big Client Redemption Blunts Quarterly Results -- Update

2025. g. 15. jūl. 20:06 UTC

Tirgus saruna

Nvidia, AMD Seen Benefiting from Return to Chinese Chip Sales -- Market Talk

2025. g. 15. jūl. 19:54 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 15. jūl. 19:54 UTC

Tirgus saruna

Meta CEO Hints at Higher Revenues, Expenses With Data Center Plans -- Market Talk

2025. g. 15. jūl. 19:38 UTC

Tirgus saruna

Oil Falls As Eventual Oversupply Concerns Weigh -- Market Talk

2025. g. 15. jūl. 19:09 UTC

Tirgus saruna

U.S. Natural Gas Futures Post Back-to-Back Gains -- Market Talk

2025. g. 15. jūl. 19:07 UTC

Tirgus saruna

Canada CFOs Willing to Take Risks, Increase Spending -- Market Talk

2025. g. 15. jūl. 19:03 UTC

Tirgus saruna

Gold Slips as Big Buyers Pull Back -- Market Talk

2025. g. 15. jūl. 18:32 UTC

Iegādes, apvienošanās, pārņemšana

Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks -- Analysis

2025. g. 15. jūl. 18:31 UTC

Iegādes, apvienošanās, pārņemšana

Waters Deal for Becton Unit Pairs Near-Term Risks With Possible Long-Term Rewards, Analysts Say

2025. g. 15. jūl. 18:13 UTC

Tirgus saruna

Canada Adopts 'Note of Realism' in US Trade Talks, Setting Stage for Possible Tariff Deal -- Market Talk

2025. g. 15. jūl. 17:40 UTC

Tirgus saruna

Canadian Inflation Adds to Case for Bank of Canada Extending Pause -- Market Talk

2025. g. 15. jūl. 17:40 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 15. jūl. 17:25 UTC

Iegādes, apvienošanās, pārņemšana

National Fuel Gas Gets Rare Double Upgrade. Buy the Stock, Analyst Says. -- Barrons.com

2025. g. 15. jūl. 17:24 UTC

Tirgus saruna

Dollar Gains Strength After Inflation Data -- Market Talk

2025. g. 15. jūl. 16:49 UTC

Tirgus saruna

Oil Futures Likely to Continue Sideways Trade -- Market Talk

2025. g. 15. jūl. 16:20 UTC

Tirgus saruna
Peļņas

Financial Services Roundup: Market Talk

2025. g. 15. jūl. 16:20 UTC

Tirgus saruna

Auto & Transport Roundup: Market Talk

2025. g. 15. jūl. 16:20 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2025. g. 15. jūl. 15:42 UTC

Tirgus saruna

Coca-Cola Seen as Top Pick Ahead of Consumer Staples Earnings -- Market Talk

Salīdzinājums

Cenas izmaiņa

Atossa Genetics Inc Prognoze

Cenas mērķis

By TipRanks

518.68% augšup

Prognoze 12 mēnešiem

Vidējais 5.63 USD  518.68%

Augstākais 7.5 USD

Zemākais 4 USD

Pamatojoties uz 4 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Atossa Genetics Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

4 ratings

4

Pirkt

0

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

0.7955 / 0.898Atbalsts un pretestība

Īstermiņā

Bullish Evidence

Vidējā termiņā

Strong Bullish Evidence

Ilgtermiņā

Weak Bearish Evidence

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Atossa Genetics Inc

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.